Hua Medicine (Shanghai) Ltd.
2552.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.22B
Close$
Share Statistics
| Market cap | $2.22 Billion |
|---|---|
| Enterprise Value | $1.50 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.09 |
| Beta | 0.81 |
| Outstanding Shares | 997,988,916 |
Return
| Return on Equity | 97.73% |
|---|---|
| Return on Assets | 64.03% |
| Return on Invested Capital | -30.22% |
Valuation & Multiples
| P/E Ratio | -18.61 |
|---|---|
| PEG | 18.16 |
| Price to Sales | 2.11 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.48 |
| Enterprise Value to EBIT | -4.48 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$575.09 M
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
$0.59
Average shareholder expectationRevenue Estimate
$870.35 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hua Medicine (Shanghai) Ltd.
424 employees
CEO: Li Chen Hua Medicine (Shanghai) Ltd., a biopharmaceutical enterprise established in 2011 and headquartered in Beijing, China, specializes in the clinical development of novel therapeutic solutions, with a primary focus on addressing diabetes wit...